KK
CGEM icon

KLP Kapitalforvaltning’s Cullinan Oncology CGEM Stock Holding History

KLP Kapitalforvaltning’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Hold
6,800
– – ﹤0.01% 2040
2026
Q1 		$96.6K Hold
6,800
– – ﹤0.01% 2061
2025
Q4 		$70.4K Hold
6,800
– – ﹤0.01% 2126
2025
Q3 		$40.3K Hold
6,800
– – ﹤0.01% 2156
2025
Q2 		$51.2K Hold
6,800
– – ﹤0.01% 2157
2025
Q1 		$51.5K Hold
6,800
– – ﹤0.01% 2191
2024
Q4 		$82.8K Buy
+6,800
New +$97.7K ﹤0.01% 2144

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

KLP Kapitalforvaltning's CGEM Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Cullinan Oncology (CGEM) position steady in Q2 2026 at 6,800 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #2040.

KLP Kapitalforvaltning first reported a position in CGEM in Q4 2024 and has held it in 7 quarters since. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • KLP Kapitalforvaltning held 6,800 shares of Cullinan Oncology worth $124K as of Q2 2026.
  • KLP Kapitalforvaltning left its Cullinan Oncology share count unchanged in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2040 holding.
  • KLP Kapitalforvaltning first reported a position in Cullinan Oncology in Q4 2024 and has held it in 7 quarters since.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.